Large-scale testing (Phase 3)UnknownNCT02186574What this trial is testingTenofovir to Prevent HBV ReactivationWho this might be right forHepatitis BLymphomaNon-Hodgkin University Health Network, Toronto 184
Large-scale testing (Phase 3)Ended earlyNCT01039376What this trial is testingOfatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction TherapyWho this might be right forLeukaemia, Lymphocytic, Chronic Novartis Pharmaceuticals 480
Early research (Phase 1)Study completedNCT00058396What this trial is testingMonoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWho this might be right forLeukemiaLymphoma Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Ended earlyNCT00324324What this trial is testingMoxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more OHSU Knight Cancer Institute 240
Early research (Phase 1)Study completedNCT00694590What this trial is testingStudy of AMD3100 (Plerixafor) and Rituximab in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWho this might be right forChronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL) Genzyme, a Sanofi Company 24
Post-approval studies (Phase 4)UnknownNCT00131313What this trial is testingEfficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.Who this might be right forChronic Lymphocytic Leukemia East Valley Hematology and Oncology Medical Group 180
Early research (Phase 1)Active Not RecruitingNCT06676033What this trial is testingEpcoritamab in Chronic Lymphocytic Leukemia and Richter SyndromeWho this might be right forLeukemia, Chronic LymphocyticRichter Syndrome National Heart, Lung, and Blood Institute (NHLBI) 5
Large-scale testing (Phase 3)Study completedNCT00005590What this trial is testingLevofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or LymphomaWho this might be right forBrain and Central Nervous System TumorsBreast CancerExtragonadal Germ Cell Tumor+7 more Cancer Research Campaign Clinical Trials Centre
Testing effectiveness (Phase 2)Study completedNCT01002755What this trial is testingLenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWho this might be right forChronic Lymphocytic LeukemiaFatigueFever+7 more M.D. Anderson Cancer Center 36
Early research (Phase 1)Ended earlyNCT00907517What this trial is testingStudy of SCH 900776 (MK-8776) With and Without Cytarabine in Participants With Acute Leukemias (P05247)Who this might be right forMyelogenous Leukemia, AcuteLeukemia, Lymphocytic, AcuteLeukemia, Lymphoblastic, Acute, Philadelphia-Positive+1 more Merck Sharp & Dohme LLC 24
Testing effectiveness (Phase 2)Study completedNCT00132015What this trial is testing17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic MastocytosisWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more National Institutes of Health Clinical Center (CC) 37
Testing effectiveness (Phase 2)WithdrawnNCT00962715What this trial is testingReactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia M.D. Anderson Cancer Center
Not applicableLooking for participantsNCT05371808What this trial is testingEconomic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:Who this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Canadian Cancer Trials Group 247
Testing effectiveness (Phase 2)UnknownNCT02851589What this trial is testingStudy Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and LymphomaWho this might be right forAcute Lymphocytic LeukemiaChronic Lymphocytic LeukemiaFollicular Lymphoma+3 more PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Not applicableLooking for participantsNCT04785989What this trial is testingIn Vivo Metabolic Profiling of CLL (Chronic Lymphocytic Leukemia)Who this might be right forChronic Lymphocytic Leukemia University of Wisconsin, Madison 16
Testing effectiveness (Phase 2)Study completedNCT01419691What this trial is testingPhase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia (CLL)Small Lymphocytic LymphomaLeukemia, Prolymphocytic University of Kansas Medical Center 15
Testing effectiveness (Phase 2)UnknownNCT02315118What this trial is testingPilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell MalignanciesWho this might be right forB-Cell Chronic Lymphocytic LeukemiaNon-Hodgkin's Lymphoma National University Hospital, Singapore 18
Early research (Phase 1)Ended earlyNCT02137889What this trial is testingSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VAY736 in Relapsed or Refractory CLL PatientsWho this might be right forRelapsed or Refractory Chronic Lymphocytic Leukemia (CLL) Novartis Pharmaceuticals 3
Early research (Phase 1)Study completedNCT01841489What this trial is testingNovel GS-9973 Tablet Formulations to Evaluate the Effect of Acid Reducing Agents, Relative Bioavailability, and Food Effect on GS-9973 PharmacokineticsWho this might be right forChronic Lymphocytic Leukemia Gilead Sciences 56
Not applicableUnknownNCT02757586What this trial is testingTreatment of Chronic Lymphocytic LeukemiaWho this might be right forLeukemia, Lymphocytic, Chronic, B-Cell Peking University People's Hospital 70